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RUNNING HEAD: Tyrosine and cardiovascular reactivity 
Abstract 1 
 Ingesting the catecholamine precursor tyrosine can prevent decrements in, or 2 
improve, cognitive and motor performance in demanding situations.  Furthermore, the 3 
biopsychosocial model of challenge and threat specifies that adrenal medullary 4 
catecholamine release plays a central role in the occurrence of a challenge state, which 5 
has been linked to better performance under pressure than a threat state.  The present 6 
study thus examined whether acute tyrosine intake impacts upon challenge and threat 7 
states or influences cognitive and motor performance independently.  A double-blind 8 
randomised crossover design with 49 participants (33 males; µage = 22.5 years, SD = 9 
5.0) was used.  Participants ingested tyrosine or placebo (150mg/kg body mass) 60 10 
minutes before performing the N-Back task and a bean-bag throwing task.  Cognitive 11 
self-reports and cardiovascular data before each task provided indicators of challenge 12 
and threat states.  There were no significant differences between tyrosine and placebo 13 
on the cognitive and cardiovascular challenge and threat variables.  Generalised 14 
Estimating Equations analyses found that tyrosine was associated with better 15 
performance than placebo on the bean-bag throwing task, but not on the N-Back task.  16 
A significant interaction effect showed that challenge and threat states were more 17 
positively related to performance in the placebo condition than in the tyrosine condition.  18 
This suggests that tyrosine may have attenuated the detrimental effect of a threat state.  19 
The present study breaks new ground in relating the impact of a dietary supplement to 20 
challenge and threat states and finding that tyrosine may in some cases attenuate the 21 
negative effects of a threat state. 22 
 Keywords: Biopsychosocial model, challenge and threat, cognitive task, 23 
demand-resource evaluations, motor task.  24 
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Tyrosine intake and cardiovascular responses in a motivated performance situation 25 
 The question of why some individuals excel in important situations whereas 26 
others struggle under pressure is of great importance, and due to the widespread 27 
occurrence of situations in which active performance is required to attain a self-relevant 28 
goal, this topic is of interest to sport, social, organisational, and clinical psychologists 29 
alike.  The biopsychosocial model (BPSM) of challenge and threat (CAT; Blascovich, 30 
2008) is a key framework for understanding performance variation under pressure 31 
across these disciplines.  It was extended and applied to the domain of sports by the 32 
Theory of Challenge and Threat States in Athletes (TCTSA; Jones, Meijen, McCarthy, 33 
& Sheffield, 2009).  In many studies, a challenge state has been associated with better 34 
performance than a threat state (for a review see Hase, O’Brien, Moore & Freeman, in 35 
press).  This relationship has led researchers to study putative challenge-promoting 36 
interventions such as imagery, stress optimisation, and quiet eye training, and their 37 
effects on performance (Jamieson, Crum, Goyer, Marotta, & Akinola, 2018; Moore, 38 
Vine, Freeman, & Wilson, 2013; Williams & Cumming, 2012).  These interventions 39 
typically aim at improving performance by optimising psychological antecedents of 40 
CAT states (e.g., self-efficacy, perceived control; Williams & Cumming, 2012), and by 41 
helping individuals interpret physiological arousal as more facilitative for performance 42 
(Jamieson et al., 2018; Moore et al., 2013).  However, these interventions have all taken 43 
psychological approaches to manipulating CAT states.  The current study therefore 44 
examined whether a nutritional intervention that targets a neurotransmitter group 45 
specified by the BPSM to be key to the occurrence of CAT states may promote a 46 
challenge state and enhance performance.  Although some nutrients and supplements 47 
(e.g., sugar and caffeine; Grasser et al., 2016; Hartley, Lovallo, & Whitsett, 2004) 48 
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exhibited effects on the cardiovascular system akin to those of CAT states, research 49 
examining dietary interventions in a CAT context is scarce.   50 
The BPSM describes CAT states as responses that only occur in motivated 51 
performance situations, which are goal-relevant, evaluative, potentially stressful, and 52 
require sufficient active performance in order for personal growth (Blascovich & 53 
Mendes, 2000).  CAT states differ in their underlying cognitive evaluations and 54 
concomitant physiological responses.  A challenge state occurs when perceived personal 55 
coping resources outweigh or equal perceived situational demands, whereas a threat 56 
state occurs when perceived situational demands outweigh perceived personal coping 57 
resources.  These demand-resource evaluations are thought to be influenced by several 58 
factors, such as self-efficacy, achievement goal orientation, perceived control, danger, 59 
uncertainty, novelty, required effort, skills, knowledge, abilities, presence of others, 60 
attitudes, and beliefs (Jones et al., 2009; Blascovich, 2008).  Physiologically, a 61 
challenge state has been hypothesised to involve an increase in sympathetic-62 
adrenomedullary axis function.  The sympathetic activation at the myocardium is 63 
thought to increase heart rate (HR; the number of heart beats per minute) and stroke 64 
volume (the volume of blood ejected by the left ventricle with each heart beat) by acting 65 
on β1 receptors at the myocardium, thereby increasing cardiac output (CO; volume of 66 
blood ejected by the left ventricle per minute).  At the same time, adrenal medullary 67 
release of epinephrine is thought to act as a vasodilator by acting on β2 receptors in 68 
skeletal muscle beds and bronchi, thereby decreasing total peripheral resistance (TPR; 69 
the degree of systemic peripheral vascular constriction; Blascovich, 2008; Blascovich & 70 
Mendes, 2000; Brownley, Hurwitz, & Schneiderman, 2000).   71 
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In addition to sympathetic-adrenomedullary activation, a threat state is also 72 
thought to involve pituitary-adrenocortical axis activation that inhibits the sympathetic-73 
adrenomedullary axis (Blascovich & Mendes, 2000).  This leads to relatively small 74 
increases in HR, little change or minor decreases in CO, and little change or small 75 
increases in TPR during a threat state.  The BPSM conceptualises CAT states as 76 
opposite ends to a bipolar continuum, meaning that one can be more or less strongly 77 
challenged or threatened, but not challenged and threatened at the same time.  It also 78 
specifies task engagement, which is conceptualised as an increase in HR or ventricular 79 
contractility (VC; the contractile state of the left ventricle; operationalised by the BPSM 80 
as the inverse of the pre-ejection period), as a prerequisite for CAT states to occur in 81 
motivated performance situations.  Hence, without task engagement neither a challenge 82 
nor a threat state will be experienced (Blascovich, 2008).   83 
Significant relationships between CAT states and performance have been found 84 
across diverse contexts.  A recent systematic review of 38 studies that conceptualised 85 
CAT in a manner consistent with the BPSM found that a challenge state was related to 86 
better performance than a threat state in 28 of those studies (Hase et al., in press).  This 87 
relationship was generally supported regardless of CAT variable (cognitive, 88 
physiological, and dichotomous), outcome task (cognitive and behavioural), and 89 
research design used (correlational, quasi-experimental, direct experimental, and 90 
indirect experimental studies).  For example, Turner, Jones, Sheffield, and Cross (2012) 91 
found that a physiological challenge state was related to better cognitive and motor task 92 
performance than a threat state, using a modified Stroop and a netball shooting task.  93 
Interestingly though, the available experimental studies only used psychological 94 
manipulations to induce CAT states.  For example, some studies manipulated CAT with 95 
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instructional sets targeting resource and demand evaluations (e.g., Feinberg & Aiello, 96 
2010; Turner, Jones, Sheffield, Barker, & Coffee, 2014), and others targeted proposed 97 
psychological antecedents of CAT states (e.g., perceived required effort; Moore, Vine, 98 
Wilson, & Freeman, 2014).  The lack of physiological manipulations might be due to 99 
pioneering studies that successfully changed cardiovascular reactivity via manipulations 100 
of cognitive CAT evaluations, but did not succeed in evoking cognitive CAT 101 
evaluations via physiological manipulations, namely cold water immersion and physical 102 
exercise (Tomaka, Blascovich, Kibler, & Ernst, 1997).  To our knowledge, however, no 103 
study has examined the effects of a catecholamine-based intervention on CAT states.  104 
The BPSM of CAT specifies the catecholamine epinephrine to be centrally involved in 105 
the occurrence of a challenge state via stimulation of the vascular and cardiac 106 
epinephrine system (Blascovich & Mendes, 2000).  Hence, a catecholamine-based CAT 107 
intervention could hold the potential to promote a challenge state and complement 108 
previous interventions.  A possible catecholamine-based CAT intervention is tyrosine 109 
intake. 110 
Tyrosine is a naturally occurring, non-essential amino acid.  It is synthesised 111 
from phenylalanine and is converted into the dopamine precursor L-3,4-112 
dihydroxyphenylalanine (L-DOPA) by the rate-limiting enzyme tyrosine hydroxylase.  113 
Tyrosine, but not its precursor phenylalanine, is able to stimulate catecholamine 114 
production in the brain, which has been observed directly and indirectly (for a review, 115 
see Fernstrom & Fernstrom, 2007).  As tyrosine hydroxylase is usually about 75% 116 
saturated (Carlsson & Lindqvist, 1978), there is a modest, but significant potential to 117 
increase L-DOPA synthesis by increasing serum tyrosine levels, which should increase 118 
when demand is heightened due to greater neuronal activity (Fernstrom & Fernstrom, 119 
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2007).  In the catecholamine pathway, tyrosine can be converted into L-DOPA, 120 
dopamine, and eventually norepinephrine and epinephrine.  Importantly, an increase in 121 
serum tyrosine can be achieved through dietary supplementation.  For example, Strüder 122 
et al. (1998) found that an acute dose of 10g of tyrosine significantly increased serum 123 
tyrosine levels in trained male cyclists within 45 minutes of ingestion, and tyrosine 124 
levels remained significantly elevated for 60 minutes following 150 minutes of cycling.  125 
Similarly, Tumilty and colleagues found that 150mg/kg body mass of tyrosine 126 
significantly increased serum tyrosine levels within 60 minutes (Tumilty, Davison, 127 
Beckmann, & Thatcher, 2014).  It should be noted, however, that other amino acids 128 
compete with tyrosine for uptake into the brain, and therefore it is advisable to 129 
administer tyrosine in a pure form and to restrict protein intake before administration in 130 
order to maximise brain tyrosine uptake (Fernstrom & Fernstrom, 2007). 131 
The main mechanism of action by which tyrosine is thought to be effective is its 132 
stabilising influence on catecholamine levels in situations of heightened cognitive or 133 
physiological demands (e.g., cognitive load, extreme temperature), thereby preventing a 134 
performance decline.  The importance of catecholamine function for cognitions, 135 
emotions, and behaviour has been demonstrated by depletion studies in which tyrosine 136 
and phenylalanine were removed from participants’ diet to elicit a depletion of brain 137 
catecholamine levels.  Such a catecholamine depletion led individuals to behave in a 138 
less motivated manner (Cawley et al., 2013; McLean, Rubinsztein, Robbins, & 139 
Sahakian, 2004; Roiser et al., 2005), experience cognitive impairments (Harmer, 140 
McTavish, Clark, Goodwin, & Cowen, 2001), and become more susceptible to the 141 
detrimental effects of low light exposure (Cawley et al., 2013).  Further, O’Brien and 142 
colleagues argued that catecholamine depletion may explain performance decrements in 143 
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demanding situations, but that this may be mitigated by tyrosine consumption (O'Brien, 144 
Mahoney, Tharion, Sils, & Castellani, 2007).  Indeed, a recent systematic review found 145 
that tyrosine intake protected or improved cognitive and motor performance under 146 
demanding conditions, while no beneficial effect was found for endurance exercise 147 
performance (Hase, Jung, & aan het Rot, 2015).  For example, beneficial effects of 148 
tyrosine intake were found on reaction times following heat exposure (Kishore et al., 149 
2013), on working memory performance following cold exposure (Mahoney, Castellani, 150 
Kramer, Young, & Lieberman, 2007; Shurtleff, Thomas, Schrot, Kowalski, & Harford, 151 
1994), and on working memory performance under cognitive load (Thomas, Lockwood, 152 
Singh, & Deuster, 1999).   153 
 Given the previously presented work showing that 1) catecholamines are 154 
involved in CAT states (Blascovich, 2008), 2) a challenge state generally relates to 155 
better performance than a threat state (Hase et al., in press), 3) tyrosine intake can 156 
increase serum tyrosine and catecholamine levels (Fernstrom & Fernstrom, 2007), and 157 
4) research has found tyrosine intake to improve cognitive and motor performance, we 158 
concluded that this evidence merits an examination of the impact of tyrosine on CAT 159 
states.  Thus, the aim of the present study was to examine whether the beneficial effect 160 
of tyrosine intake on cognitive and motor performance is associated with a facilitation 161 
of a challenge state at physiological and psychological levels.  We hypothesised that 162 
participants would exhibit relatively greater challenge reactivity (greater CAT index 163 
calculated from CO and TPR reactivity from baseline to post-task instructions) after 164 
tyrosine ingestion than after ingestion of a placebo (H1).  In an exploratory manner, we 165 
also examined a potential effect of tyrosine on cognitive CAT evaluations.  We also 166 
hypothesised that participants would perform better on a cognitive and a motor task 167 
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after tyrosine ingestion than after placebo ingestion (H2).  Finally, we hypothesised that 168 
a challenge state (measured as cardiovascular responses and cognitive evaluations) 169 
would be related to better performance than a threat state (H3). 170 
Method 171 
Participants 172 
 The sample consisted of 49 students and staff members (33 male, 16 female) at a 173 
UK university, who were recruited with convenience sampling in person and through 174 
the university e-mail system.  Participants were 18 to 46 years old, with a mean of 22.5 175 
years (SD = 5.1).  Participants’ mean height and body mass were 175.0 cm (SD = 10.0) 176 
and 74.7 kg (SD = 13.6), respectively.  All participants reported being healthy, right-177 
handed or ambidextrous, and most participants were native English speakers (61%)
1
.  A 178 
minimum sample size of 41 was determined with a power calculation in G*Power 179 
3.1.9.2., using the N-Back task effect sizes (average d = 1.04) reported in Hase et al.’s 180 
(2015) systematic review, because no further effect sizes were found for the effect of 181 
tyrosine on motor performance or CAT states.  Hence, the calculation used effect size d 182 
= 1.04 (f = 0.52), α = 0.05, and 90% desired power for a two-group, two-measurement 183 
comparison. 184 
Materials 185 
 Cardiovascular data.  The Portapres Model-2 (Finapres Medical Systems BV, 186 
Amsterdam, the Netherlands) was used to record cardiovascular variables: HR, TPR, 187 
and CO.  Its measurement method is based on the arterial volume-clamp method of 188 
Peñáz (1973) and the physiological calibration criteria for the proper unloading of the 189 
finger arteries of Wesseling (1996).  Further, it uses a height correction unit to 190 
                                                          
1
 Native language (coded dichotomously for English versus Non-English), was not significantly 
correlated with performance on either of the two tasks. 
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compensate for hydrostatic pressure changes due to movement of the hand.  It has been 191 
used in previous CAT research and allows for continuous data recording (Moore, 192 
Young, Freeman, & Sarkar, 2018; Zanstra, Johnston, & Rasbash, 2010).  It has been 193 
validated against the Finapres and the Oxford method in previous research and was 194 
found to be accurate, reliable, and cause no more missing data due to artefacts than the 195 
Oxford method (Hirschl, Woisetschläger, Waldenhofer, Herkner, & Bur, 1999; Imholz 196 
et al., 1993).  Data were converted and downloaded with Beatscope version 1.1a.   197 
Dietary supplements.  Consistent with comparable previous studies (e.g., 198 
Shurtleff et al., 1994; Tumilty et al., 2014), the protocol used 150 mg / kg body mass of 199 
L-tyrosine in powder form (Myprotein.co.uk, Meridian House, Cheshire, UK) for the 200 
tyrosine condition and 150 mg / kg body mass of microcrystalline cellulose (Blackburn 201 
Distributions Ltd, Nelson, Lancashire, UK) for the placebo condition.  Both powders 202 
were mixed with 200 ml of 100% pure squeezed orange juice (Tesco Stores Ltd., 203 
Welwyn Garden City, Hertfordshire, UK). 204 
 Demand-resource evaluations.  Demand-resource evaluations were assessed 205 
with two items used by previous research (e.g., Vine, Freeman, Moore, Chandra-206 
Ramanan, & Wilson, 2013).  The items were: “How demanding do you expect the 207 
upcoming task to be?” for demands and “How able are you to cope with the demands of 208 
the upcoming task?” for resources.  All items were scored on a seven-point Likert scale 209 
anchored by not at all (1) and extremely (7).  A cognitive CAT variable was then 210 
created from these items by subtracting demands from resources, meaning that possible 211 
scores ranged from -6 to 6 and denoted more challenge as values increased. 212 
N-back task.  The N-Back task is a test of working memory that has been used 213 
in previous tyrosine supplementation research (e.g., Colzato, Jongkees, Sellaro, & 214 
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Hommel, 2013).  A Qualtrics survey presented a string of 23 letters for five seconds 215 
each.  Starting at the fourth letter, participants were prompted to indicate (by selecting 216 
one of two boxes indicating yes or no) whether the letter shown on the current screen 217 
was the same as the letter shown three earlier (3-back condition).  Thus, there were 20 218 
items in total, 10 of them requiring yes and 10 of them requiring no as the correct 219 
answer.  The maximum time was five seconds, after which the page automatically 220 
advanced if no response had been given.  The number of correct answers was used as 221 
the performance outcome. 222 
Bean bag throwing task.  Bean-bag throwing has been used as a task in 223 
previous CAT research (Turner et al., 2014).  This task consisted of 20 throws of a bean 224 
bag from a distance of 4 m to a 50x50 cm quadratic target on the laboratory floor.  The 225 
bean bag weighed 80 g and was approximately 6 cm long, 5 cm wide, and 5 cm high.  226 
Participants scored one point each time the bean bag came to rest on the target.  This 227 
scoring method was adopted in order to ensure commensurability with N-Back task 228 
scores.  The number of points scored was used as the performance outcome.   229 
Procedure 230 
 The study was approved by an institutional ethics committee and used a double-231 
blind randomised crossover design.  The total duration of each session was 90 minutes.  232 
One day before testing, the experimenters sent participants a list of tyrosine- or protein-233 
rich foods to avoid in the 12 hours before testing, instructed participants not to consume 234 
any psychoactive substances (including alcohol and caffeine), and asked participants to 235 
avoid consuming any food or drinks (except water) in the last three hours before testing.  236 
Upon entering the laboratory, participants were given an information sheet and provided 237 
informed consent.  The information sheet explained the study and highlighted that 238 
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rewards would be given to the best three performers on each task.  Participants were 239 
randomly assigned to receive either tyrosine or the placebo in the first of two testing 240 
sessions.  Participants were then weighed on a SECA 770 scale (Vogel & Halke, 241 
Hamburg, Germany) in order to calculate the appropriate supplement dosage, which 242 
was mixed with orange juice by an experimenter who was not involved in the rest of the 243 
study.  After consuming the drink, participants waited for 60 minutes outside of the 244 
laboratory.  After that, a second experimenter blind to the supplement condition called 245 
participants in to sit in front of a computer, on which a Qualtrics survey was opened to 246 
guide them through the study.  For the first week, participants were asked to provide 247 
demographic information and questions about their food intake on the test day before 248 
moving on to the main part of the study.  The experimenter then put the Portapres on the 249 
left hand of participants, with the cuff around the middle finger and the height 250 
correction sensor around the upper arm at the height of the sternum.  Participant age, 251 
sex, height, and weight were entered to calibrate the Portapres.  Participants sat still for 252 
the entire duration of the cardiovascular recordings. 253 
The order of the two tasks was randomised on each measurement occasion.  254 
Before starting each task, cardiovascular responses were recorded for a baseline of three 255 
minutes.  Participants then read through the respective task instructions (MReading time = 256 
29.00 s, SD = 22.28 s).  For each task, the survey reminded participants of the £30, £20, 257 
and £10 rewards for the best three performers, and that a quicker task completion time 258 
would determine the winner between participants with the same score.  Participants then 259 
confirmed that they had read and understood the instructions.  Participants were then 260 
instructed to sit still and think about the upcoming task for one minute.  This minute 261 
provided the task-specific cardiovascular reactivity to be compared against the last 262 
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minute of baseline.  Participants subsequently completed the demand-resource 263 
evaluation items, before beginning the first task.  After participants finished the first 264 
task, the procedure was repeated for the second task (baseline, task instructions, one-265 
minute reactivity recording, demand-resource evaluation items, perform task).  266 
Approximately six minutes separated the end of the first task from the beginning of the 267 
second task.  After finishing both tasks, participants were thanked for their time and 268 
reminded to return one week later at the same time to repeat the process with the other 269 
supplement.   270 
Statistical Analysis 271 
 Consistent with previous research using the BPSM of CAT (e.g., Mendes, 272 
Blascovich, Hunter, Lickel, & Jost, 2007), mean HR, TPR, and CO values were 273 
calculated for the final minute of each baseline and also for the one minute of each 274 
reactivity period.  Four univariate outliers (values more extreme than three standard 275 
deviations from the mean; Stevens, 2009) were winsorised to be 1% more extreme than 276 
the next non-outlying score (adapted from Shimizu, Seery, Weisbuch, & Lupien, 2011).  277 
The baseline values for CO and TPR were then regressed on their respective reactivity 278 
values with the standardised residuals being saved to create residualised change scores 279 
in order to adjust for baseline differences (RCS; Burt & Obradovic, 2013).  TPR RCS 280 
were then multiplied by -1 and summed with the CO RCS to create a single 281 
physiological CAT index for each task.  To test task engagement, a paired-samples t-test 282 
compared mean HR between the baseline and reactivity period.  283 
To test the first hypothesis, paired-samples t-tests compared physiological CAT 284 
scores between the experimental conditions on each task.  As an exploratory analysis, 285 
these tests were repeated for evaluations of cognitive CAT, demands, and resources.  286 
Tyrosine and cardiovascular reactivity 
15 
 
Furthermore, a correlation analysis controlling for condition examined the association 287 
between cognitive and physiological CAT scores for each task.  To test the hypotheses 288 
that CAT states are associated with performance, and that performance would be better 289 
on tyrosine than on placebo, two generalised estimating equations (GEE) models were 290 
run to analyse the relationship between performance on each task with experimental 291 
condition, cognitive CAT, physiological CAT, and the two-way interaction terms of 292 
condition with cognitive and physiological CAT
2
.  The GEE models were selected 293 
because they allow for the test of relationships between a set of independent variables 294 
and a dependent variable across different measurements, which is a parsimonious 295 
alternative to multiple separate analyses, and also allows for the inclusion of interaction 296 
effects between predictors.  Significant interaction effects in the GEE analyses were 297 
probed by multiple linear regression analyses that determined simple slopes for the 298 
relationship between CAT and task performance for the respective task and condition 299 
using both CAT variables as predictors.  300 
Results 301 
Two participants failed to attend the second test, leading to a final sample of 47.  302 
All final analyses excluded cases that did not indicate physiological engagement with 303 
the respective task, which is a premise for the analysis of CAT states within the BPSM 304 
(Blascovich, 2008).  This lack of task engagement was evidenced by a lack of increase 305 
in HR from baseline to post-instructions
3
.  For the remaining participants (37 on the N-306 
                                                          
2
 In order to control for potential confounders, these analyses were repeated including age, completion 
time, sex, and task order as predictors. As there were no significant effects for these control variables on 
either task, they were not included in the main analyses. Ancillary GEE analyses also showed that they 
were not significantly associated with physiological CAT, although a marginally significant trend (p = 
0.07) toward more challenge at older age was observed on the N-Back task. 
3
 On the N-Back task, 36 cases (40%) were excluded. On the bean-bag throwing task, 44 cases (49%) 
were excluded. Since this type of analysis has not been done before, we also report the results of our 
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Back task and 36 on the bean-bag throwing task), HR increased significantly from 307 
baseline to post-instructions [MN-Back = 5.34, SD = 3.63, t(53) = 10.81, p <.001, d = 308 
1.47; MBean-bag = 4.79, SD = 3.53, t(44) = 9.09, p <.001, d = 1.35].  There were no 309 
significant differences between baseline cardiovascular values for the first and second 310 
task, indicating that participants returned to their baseline values after performing 311 
(MTask1-Task2 = -1.02; t(44) = -0.84, p = .40).  312 
Comparison of CAT by Experimental Condition and Task 313 
 Table 1 presents descriptive statistics for systolic, diastolic, and mean arterial 314 
blood pressure; HR; CO; and TPR by task and condition.  Table 2 summarises the 315 
paired-samples t-test comparing the placebo and tyrosine conditions on physiological 316 
CAT. cognitive CAT, demands, and resources for both tasks.  There were no significant 317 
differences between conditions on the two tasks for any of the variables.  Cognitive and 318 
physiological CAT were not significantly correlated on the N-Back task (r = -.07, p = 319 
.61) or the bean-bag throwing task (r = -.10, p = .51).   320 
Task Performance Analysis 321 
N-Back Task. Table 3 summarises the GEE analysis of performance on the N-322 
Back task.  There were no significant main or interaction effects. 323 
Bean-bag Throwing Task. Table 4 summarises the GEE analysis of 324 
performance on the bean-bag throwing task.  There was a significant main effect for 325 
condition (B = -1.94, Wald χ² = 4.03, p =.05, 95% CI [-3.82, -0.05]), with superior 326 
performance in the tyrosine condition than in the placebo condition.  There also was a 327 
                                                                                                                                                                          
analyses using the traditional approach in an online supporting material. The significant condition effect 
favouring tyrosine over placebo on the bean-bag throwing task, but not the significant 
condition*physiological CAT interaction effect was replicated in these analyses. Though HR increased 
significantly on the N-Back task (M = 1.80, t(89) = 2.48, p = .02, d = 0.26), it did not significantly increase 
on the bean-bag throwing task (M = 0.47, t(88) = 0.57, p = .57, d = 0.06). 
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significant interaction effect for condition*physiological CAT (B = 1.15, Wald χ² = 328 
5.51, p =.02, 95% CI [0.19, 2.11]), with physiological CAT more positively related to 329 
performance in the placebo condition than the tyrosine condition.  The additional 330 
regression analyses showed that physiological CAT was neither significantly related to 331 
performance in the placebo (B = 0.58, t[19] = 1.53, p = .14, sr² =.10), nor in the tyrosine 332 
condition (B = -0.58, t[20] = -1.76, p = .09, sr² = .13).  The same was found for 333 
cognitive CAT in the placebo (B = 0.35, t[19] = 1.28, p = .22, sr² =.07) and in the 334 
tyrosine condition (B = 0.05, t[20] = 0.15, p = .88, sr² = .00). 335 
Discussion 336 
 The present study tested whether tyrosine intake enhances challenge responses 337 
(H1) and improves performance relative to placebo on a cognitive and a motor task 338 
(H2).  It also tested whether challenge responses are related to better performance than 339 
threat responses (H3).  While the data did not support the first hypothesis, partial 340 
support was found for the second hypothesis as tyrosine was related to better 341 
performance than placebo on the motor task.  Finally, there were no main effects for 342 
CAT states on performance, although a significant interaction effect showed that 343 
physiological CAT was more positively related to performance in the placebo condition 344 
than in the tyrosine condition. 345 
 There were no significant differences between conditions on physiological CAT.  346 
The loss of participants due to lack of task engagement may have been partially 347 
responsible for this, as small effect sizes were observed on both tasks (dN-Back = 0.18, 348 
dBean-bag = 0.23; Cohen, 1992).  As tyrosine has been found to be most effective in 349 
situations with high cognitive load or strong environmental stressors (Hase et al., 2015), 350 
it may be that stronger effects would be found in future studies that impose more 351 
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cognitive load or stress on participants than the current study did, thereby increasing 352 
demand evaluations.  This could be done by manipulating determinants of demand 353 
evaluations like uncertainty, danger, and required effort (Jones et al., 2009).  The BPSM 354 
(Blascovich, 2008) provides another potential explanation for the null findings, as it 355 
suggests that cognitive evaluations trigger physiological responses, and not vice versa.  356 
Specifically, Tomaka et al. (1997) demonstrated that evoking cardiovascular responses 357 
consistent with CAT states via exercise (versus rest) and warm (versus cold) water 358 
immersion prior to a cognitive task did not alter cognitive evaluations.  As such, 359 
tyrosine might not influence cognitive evaluations.  However, the BPSM acknowledges 360 
the dynamic nature of CAT states at a psychological level, for example via reappraisal.  361 
Hence, a physiological intervention that produces a noticeable effect on the 362 
psychological level might also effectively manipulate perceived coping resources and 363 
demands via reappraisal.  The lack of association between the two CAT measures across 364 
both experimental conditions further complicates the conclusions drawn from the 365 
present study and poses a critical finding to the predictions of the BPSM, which posits 366 
cognitive and physiological CAT states to be interrelated (Blascovich, 2008). 367 
 Tyrosine was associated with superior motor performance.  Similarly, O’Brien 368 
et al. (2007) found that tyrosine facilitated marksmanship performance, but that effect 369 
followed cold water immersion.  The current findings are thus unique in highlighting 370 
that the beneficial effect of tyrosine on motor performance is not contingent on cold 371 
water immersion.  The lack of significant differences between tyrosine and placebo on 372 
the present cognitive task is inconsistent with previous findings from studies with and 373 
without cold exposure (Colzato, Jongkees, Sellaro, & Hommel, 2013; Mahoney, 374 
Castellani, Kramer, Young, & Lieberman, 2007; O'Brien et al., 2007).  However, only 375 
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one of these studies used the N-Back task (Colzato et al., 2013).  Although that study 376 
found significant differences between tyrosine and placebo on a less demanding 377 
condition of the N-Back task (2-Back), it featured a greater number of stimuli, shorter 378 
presentation time per stimulus, and shorter stimulus-onset asynchrony.  It is unclear 379 
whether these differences caused participants to perceive higher demands and feel more 380 
pressurised.  An alternative explanation could be that the 2-back condition simplified 381 
the working memory component of the task enough to let other domains of cognitive 382 
function become the deciding factor in determining performance (e.g., sustained 383 
attention or response execution rather than working memory).  This could serve to 384 
explain why different results were found in the past and present studies.   385 
On the motor task, there was a significant interaction effect between condition 386 
and physiological CAT.  In particular, physiological CAT was more positively related 387 
to performance in the placebo condition than in the tyrosine condition.  Follow-up 388 
analyses revealed that although the regression slope for physiological CAT was in the 389 
predicted direction in the placebo condition, this trend was not statistically significant.  390 
In the tyrosine condition, the trend was in the opposite direction.  This finding is 391 
inconsistent with the general predictions of the BPSM (Blascovich, 2008) and the 392 
findings of a recent systematic review of the relationship between CAT states and 393 
performance (Hase et al., in press).  They might in part be explained by the temporal 394 
gap between CAT measurement and task performance, allowing for variation in CAT 395 
states, although previous research has found a relationship between CAT states and 396 
performance with comparable or even longer gaps (e.g., Blascovich, Seery, Mugridge, 397 
Norris, & Weisbuch, 2004).  Similarly, the relatively large number of trials could also 398 
have provoked variation in CAT states throughout task performance, therefore 399 
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attenuating the relationship between the initial CAT measurement and performance at 400 
the end of the task.  The fact that the relationship between physiological CAT and 401 
performance in the tyrosine condition was negative (albeit non-significantly so) might 402 
appear counterintuitive, but could suggest that tyrosine is particularly beneficial for 403 
those individuals experiencing a threat state and less helpful for those in a challenge 404 
state, potentially even hampering performance for strongly challenged individuals.   405 
Given the lack of differences between conditions on the CAT variables in the 406 
present study, alternative pathways through which tyrosine exerts beneficial effects on 407 
performance warrant consideration.  Rather than directly influencing CAT states, the 408 
current findings suggest that tyrosine may operate independently to improve motor 409 
performance.  Although this independent mechanism has not been explored yet, a 410 
possible candidate could be an effect of tyrosine on dopamine function in the striatum, 411 
whose activation has been linked with areas associated with action preparation and 412 
execution, such as the postcentral gyrus, precentral gyrus, and supplementary motor 413 
area (Molenberghs, Trautwein, Böckler, Singer, & Kanske, 2016).  However, future 414 
research should examine whether this finding can be replicated and explained in more 415 
detail.  For example, research could identify whether tyrosine helps threatened 416 
individuals to actually adopt a challenge state while performing a task, or whether these 417 
individuals remain threatened, but still outperform challenged individuals. 418 
Despite the strengths of the study in exploring the impact of a dietary 419 
supplement on CAT states and performance across both a cognitive and motor task, 420 
some limitations should be acknowledged.  Although participants were encouraged to 421 
perform well and financial incentives were offered, task engagement was still low in 422 
some participants.  Specifically, some participants showed decreases or no change in 423 
Tyrosine and cardiovascular reactivity 
21 
 
HR, failing to meet the BPSM’s premise of task engagement (Blascovich, 2008), and 424 
were subsequently excluded from the analyses.  The lack of verbally delivered 425 
instructions and extrinsic motivators such as performance-contingent punishments and 426 
social evaluation might be partly responsible for this.  Further, the mean increases in 427 
HR were rather small, although it should be noted that during the recordings, 428 
participants were seated and quietly imagined the upcoming task, which should provoke 429 
lesser increases in HR due to being less metabolically demanding than, for example, 430 
holding a speech (e.g., Blascovich et al., 2004).  The lack of a VC measure also limits 431 
the study, as an index based on HR and VC could have been a more robust indicator of 432 
task engagement than HR reactivity alone (e.g., Streamer, Seery, Kondrak, Lamarche, & 433 
Saltsman, 2017).   434 
Another limitation concerns the generalisability of the findings to well-learned 435 
tasks or metabolically demanding tasks (i.e., anaerobic performance; Jones et al., 2009), 436 
as both tasks in the present study were novel to the vast majority of participants and did 437 
not involve any strenuous physical exercise.  A field study in a high-pressure 438 
environment (e.g., a professional sports competition) could prevent these limitations by 439 
examining expert performance in participants likely to show greater task engagement.  440 
A third limitation is the lack of a manipulation check comparing plasma tyrosine and 441 
catecholamine levels immediately before supplement ingestion and testing.  However, 442 
similarly designed studies that used an equal or slightly lower dosage have found that 443 
plasma tyrosine increased significantly within 60 minutes of consumption (Strüder et 444 
al., 1998; Tumilty et al., 2014), and that tyrosine may increase plasma catecholamines 445 
relative to placebo (Kishore et al., 2013).   446 
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 Future research could measure physiological CAT states throughout task 447 
performance in order to explore the dynamic relationship between CAT states and 448 
performance and the present finding that tyrosine can benefit individuals in a threat state 449 
more than those in a challenge state.  More specifically, research could test whether the 450 
negative relationship between CAT states and performance on tyrosine will persist 451 
during task performance, or whether it promotes a challenge state in threatened 452 
participants during task performance, but not during task preparation.  Future work 453 
could also benefit from increasing the ecological validity of tyrosine supplementation 454 
research by looking at CAT variables in the context of sports competitions or university 455 
exams.  Indeed, the relationship between CAT states and performance has been 456 
explored in those contexts, but studies have yet to examine the impact of tyrosine intake 457 
on CAT states in those contexts (Blascovich et al., 2004; Seery, Weisbuch, Hetenyi, & 458 
Blascovich, 2010).  Further, research on CAT manipulations is still limited.  With the 459 
current exception, research has only manipulated psychological antecedents of CAT 460 
states with instructional sets or other psychological techniques (e.g., Feinberg & Aiello, 461 
2010; Moore, Vine, Wilson, & Freeman, 2015).  The BPSM of CAT provides other 462 
possibilities for physiological CAT interventions that warrant exploration (e.g., 463 
decreasing TPR with the nitric oxide precursor L-arginine; Moncada, Palmer, & Higgs, 464 
1991).  Ultimately, sports psychologists and other professionals should look to develop 465 
a multi-method toolkit containing several interventions that can reliably promote a 466 
challenge state or buffer the detrimental effect of a threat state on performance. 467 
Conclusion 468 
 The present study was the first to test the effects of tyrosine intake relative to 469 
placebo in a BPSM framework.  In a financially incentivised competitive setting, 470 
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tyrosine was associated with better performance than placebo on a motor task.  Tyrosine 471 
produced no significant differences on cognitive evaluations and cardiovascular 472 
responses.  However, cardiovascular responses were negatively related to performance 473 
on tyrosine, while a positive trend was found on placebo.  The finding that tyrosine 474 
improved motor performance holds relevance for individuals requiring fine motor 475 
performance, as tyrosine presents an effective and safe supplement to optimise their 476 
performance under pressure.  477 
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RUNNING HEAD: Tyrosine and cardiovascular reactivity 
Table 1 
Descriptive Statistics for Cardiovascular Data by Task and Condition 
Note. BL = Last minute of baseline period, DBP = Diastolic blood pressure, MAP = Mean arterial pressure, RP = Reactivity period, SBP = Systolic 
blood pressure.   
 
 N-Back Task Bean-Bag Throwing Task 
 Placebo Tyrosine Placebo Tyrosine 
 BL RP BL RP BL RP BL RP 
 M SD M SD M SD M SD M SD M SD M SD M SD 
1. HR (bpm) 71.46 12.15 77.97 11.96 70.24 10.42 74.71 10.96 74.92 8.11 80.11 9.94 71.89 11.51 76.30 11.20 
2. CO (lpm) 4.80 2.13 5.30 2.28 5.18 1.64 5.35 1.78 5.17 1.40 5.18 1.97 5.21 1.72 5.29 1.89 
3. TPR 
(mmHg.s/ml) 
1.30 0.62 1.29 0.88 1.16 0.50 1.13 0.58 1.13 0.49 1.20 0.61 1.12 0.61 1.24 0.80 
4. SBP (mmHg) 134.33 37.23 137.67 30.88 129.74 34.28 129.22 36.11 125.40 35.18 126.22 36.18 120.17 26.40 120.76 20.66 
5. DBP (mmHg) 72.58 22.02 74.87 20.18 69.52 17.86 68.84 18.27 72.12 19.63 71.95 17.79 68.49 17.14 69.85 15.31 
6. MAP (mmHg) 90.28 24.83 91.90 21.80 86.61 20.45 85.48 20.98 88.16 22.75 87.60 21.89 83.88 17.75 85.14 15.73 
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Table 2 
Descriptive Statistics and Paired-Samples T-Tests for Cognitive CAT, Physiological CAT, Demands, and Resources by Task 
 
 N-Back Task Bean-Bag Throwing Task 
 Placebo Tyrosine  Placebo Tyrosine  
 M SD M SD t (df) p d M SD M SD t (df) p d 
1. Cognitive CAT 1.00 2.15 0.70 1.80 1.01 (46) .32 0.15 1.94 2.29 1.91 1.98 0.06 (46) .95 0.01 
2. Physiological CAT 0.21 2.23 -
0.18 
1.66 0.74 (16) .47 0.18 0.34 1.59 0.06 1.78 0.69 (7) .51 0.23 
3. Demands 3.85 1.33 4.04 1.23 -1.01 (46) .32 0.15 3.11 1.45 3.22 1.35 -0.48 (46) .64 0.07 
4. Resources 4.85 1.29 4.74 1.17 0.54 (46) .59 0.08 5.05 1.44 5.13 1.27 -0.30 (46) .77 0.04 
 
RUNNING HEAD: Tyrosine and cardiovascular reactivity 
Table 3 
GEE Parameter Estimates (N-Back Task) 
Source B Wald Chi-Square Sig. 
Condition 0.55 0.77 .38 
Cognitive CAT -0.39 1.39 .24 
Physiological CAT -0.27 0.69 .41 
Condition * Cognitive 
CAT 
-0.18 0.24 .63 
Condition * 
Physiological CAT 
-0.15 0.10 .76 
Intercept 15.72 814.69 .00 
Note. Dependent variable: Performance. N = 37. 
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Table 4 
GEE Parameter Estimates (Bean-bag Throwing Task) 
Source B Wald Chi-Square Sig. 
Condition -1.94 4.03 .05 
Cognitive CAT 0.05 0.04 .85 
Physiological CAT -0.58 2.23 .14 
Condition * Cognitive 
CAT 
0.30 0.68 .41 
Condition * 
Physiological CAT 
1.15 5.51 .02 
Intercept 8.01 207.89 .00 
Note. Dependent variable: Performance. N = 36. 
